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Introduction
Brachytherapyis well-established procedure thatusesencap-
sulated small radioactive sources and delivers high dose to a
shortdistance.Thetraditionalbrachytherapy treatmentwithlow
dose rate (LDR) source has been replaced with remote
afterloading high doserate(HDR)treatment,becauseitprovides
a more convenient treatment to patients and safer work
environment to medical personal.
The modern HDR brachyther py treatment planning relies
heavilyonadose-op imizationcomputersoftwarethatcantailor
dosestospecific clinical needs.Theoptimization process involved
the computation of dwell times for a set of dwell positions
delivering a prescribed dose to a set of target or dose constraint
points, and provided isodose distribution in a three-dimensional
space.
With the availability of sophisticated imaging, such as
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magnetic resonance images or computed tomography images,
HDR brachytherapy treatment planning isbecoming more in-
dividualized,which increases the dependency of isodose dis-
tribution in the treatment plans. One of the accompanying
problems with the described development is the necessity of
quality assurance of HDR treatment planning system that
verifies not only the point dose accuracy but also isodose
distributions independently.
In external radiation therapy treatment planning systems,
the accuracy of isodose display is required to be accessed in
a quality assurance, since it plays an important role in the
determination of a proper plan.1,2)If isodose distribution p lays
a significant role in the individualized HDR brachytherapy
planning, the same standard ofquality assurance needs to be
applied.
We, therefore, developed computer software that can in-
dependently verify the accuracy of dose optimization module
aswellastheisodosedistribution of H D R treatment planning
systems.Additionally, the developed software has a function
that allows to superimpose user selected isodose lines on the
simulation and MR images of a patient, that potentially
serves to improve the quality of treatment plans.
MaterialsandMethods
1. Dose computation algorithm
The QA software was originally developed to work with
Gamma-Med 12i HDR remote afterloading planning system
and later modified to apply to Nucletron remote afterloader.
The two versions,however, have an identical algorithm and
a structure except for the source information. The software
was coded using an IDL 5.2 (Intersys, USA) and employed an
Interstitial Collaborative Working Group ICWG formalism for
dose computation.3,4)
The dose calculation formula is briefly introduced for com-
prehensive understanding. The dose rate ( ) at a point(r, ) isθ?
S K G(r,Γ θ) F(r,θ) g(r)
?(r,θ) = ----------------------- Eq(1)
G (1, /2)π
where r is a radial distance from the origin of the
coordinates and is a polar angle from the longitudinal axisθ
of he source. Cylindrical symmetry is assumed. SK is air
kerma stre th that decays exponentially, i.e. SK (T)=SKoexp(-ln
2T/Tf), where T the elapsed time from the date of
calibration. Tf is half life, and SKo is calibr ted strength.
Here, the unit o f t h e SK is U t atis definedascGycm2h-1.Γ
is a dose rate constants that is defined as (1, /2)/Sπ? Ko in
thewater.For Ir 192 source,Λ was set to 1.12 cGy hr-1U -1
following the recommendation by TG-43 report.3) G(r,θ) is a
geometry factor that approximates the source geometry. In
the d velop d software, we used a point source
approximation that was an inverse square function of the
radial distance r, i.e.1/r2. g(r) s a radial dose functionwhich
is approxim ted by Meisberger's polynomial, which is
g(r)=ao+a1r+a2r2+a3r3 (ao= 1.0128, a1=5.01×10-3, a2=-1.178×10-3,
a3=-2.008×10-3).5) F(r,θ) is an angular anisotropy factor
provided by the source vendor. The sourcespecificvaluesof
S Ko and Tf need to be enter d into the code.
Thedos at a point (r,θ)can be computed bysumming all
source's contributions to that point with the assumption that
the ose rat is constant during the treatment period. The
dose at a int can be expressed as,
D (r,θ)=Σi=N ?i (ri,θ ) Ti. Eq(2)
N is thenumberofsource dwell positions, Tiisdwelltimeof
ithsource, and (ri,θi) is a vector from the center of the ith
s urce to the dose computationpoint (r,θ).
2. Dose computation process and isodose display
For the verif cation of plans, the software needed user
input data, which were a prescribed dose, number and
positions of source dwellings, dwell times, and the date and
time of patient plan generated. A user also needed to enter
the three orthogonal plans where the dose distributions
should be displayed. For the given information, the program
firstly computed the activity of the source at the time of
patient p lanning. Then a set of linear equations was solved
tofindthesource dwell times thatsatisfied the prescriptions.
For thecomputed source dwelltimes, the dosedistributionon
a 10× 12×10 cm3 (or10×10×10 cm3 for benchmark plans)
of grid space was computed for the given source
information. The computation grid size was 1 mm for the
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benchmark plans, b u t w a s changed to 2 mm for the clinical
plans in order to increase the computation speed while
keeping the accuracy at a reasonable level. The dose
distribution was normalized to the dose at a prescription
point.
Next, the selected patient digital image files, which were
posterior and lateral simulation images and axial and saggital
MR images, were imported into the computerprogram.After
that, the images popped up on the monitor automatically and
the user was asked to click the OS point on each of the
images. Thesoftware then matched the point (5 cm, 5 c m , 5
cm)of the grid space to the OS point and superimposed the
user selected isodose lines on each of the images. Finally, all
dosimetric information, plan-specific source information, and
computation results were printed out on papers. The flow of
the computation process is summarized in Fig. 1.
3. Generation of benchmark plans
In order to test the accuracy of the developed QA
software, three benchmark plans were generated. The three
plans consisted of one, three, and five dwell positions which
were located on the y-axis of the coordinate respectively
(x-axis: left-right direction, y-axis: superior-inferior direction,
z-axis: anterior-posterior direction). 100 cGy was prescribed
to the point located 1 cm away from the source dwell axis.
The computed source dwelltimesandisodoselines of theQ A
software were compared to RTP results.
For the comparison of the isodose lines of the two
software, the prescription point on the x-axis was selected
and the dose distribution was normalized to that point. The
comparison wasmadebyprinting out the isodose lines of Q A
software on transparent papers and superimposing them on
the RTP results.
4. Apply to clinical plans
For the application to the clinical p lans, the QA code was
changed tousetheRTPcomputedsourcedwelltimesinstead
of the independently computed dwell times in order to
increase the computation speed. The accuracy of the
absolute dose was compared at A and B points for 9
intracavitary treatment patients.
Results
The source dwelltime comparisons of the benchmark plans
are presented in Table 1. As shown, the total dwell times
agreed within 2.8% errors. This deviation was possibly due to
the parameter values used in the RTP, since different values
of dose rate constant ( ) and coefficients of Meisberger'sΛ
polynomialwerefoundintheliteratures.4,6)Truly,wh n1.1 1
cGy hr-1 U -1 was used for dose rate constant, according to
Table 1. Source Dwell Time Comparison of the QA Software with GammaMed
==================================================================
S urce dwell time (total dwell time) (sec)
Number of source ---------------------Percentage difference
GammaMed QA software
-----------------------------------------------------------------------------------------------------
1 10.7 10.45
3 8 7.87
2.7 2.47
8 7.87
Total dwell time (18.7) (18.2)
5 6.7 6.51
4 3.94
4 3.83
4 3.94
6.7 6.52
Total dwell time (25.4) (24.7)
Fig. 1.Flow chart of the QA software.
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the reference 6, the agreement was improved with the
average error of 1.7%.This error could partly attribute to
the different time of plan generation, that resulted in
different activity of the source and could partly attribute to
numerical noise in solving equations. The isodose linesforall
of the three benchmark plans agreed very well as presented
in Fig. 2 even though a slight deviation was observed near
the tip of the source, where the source had high anisotropy.
This could relevant to the limitation of the spatial accuracy
of the software.
Our preliminary results of the clinical plans were 3.3% of
deviation (ranged from 0.7% to 7%) at point A and 3.4% of
deviation (ranged from 1.2% to 8.5%)atpointBaspresented
in Table 2. The larger deviation compared with the
benchmark plans possibly attributed to the increased dose
grid size and complicated source dwell positions that had
sub-milimeter scales. One representative image of isodose
superimposed on simulation images is illustrated in Fig. 3.
Discussion and Conclusion
For the safe treatment of HDR brachytherapy, the quality
assurance for the treatment planning system as well as the
individual plan is a legal requirement in some country.7)
Variouspoint dose verification algorithms that meet the
requirement, therefore,havebeen developed. Some of them,
however, were specific to particular procedures such as
single- catheter or two catheter-types.8 12)˜ A softwa e that
could be applied to vazrious procedures was,later, developed
by using commercial LDR algorithm.13) A fully automated
software that employed Meisberger's polynomial and
anisotropy table was introduced by Cohen et al.14) None of
the software,however, had a function that verified the dose
distribution.
Pointdose verification of each patient treatment plan isan
essential item recommended by AAPM, but it is minimal for
the quality assuranceofthepatientplan.15) All plans' isodose
distribution may not necessarily need to be double-checked,
Fig. 2.Isodose comparison of the QA software with GammaMed on (A) a sagittal plane and (B) a coronal plane. Black solid lines: TPS
generated isodose lines. Red dots or lines: QA software generated isodose lines.
 
A B
J Korean Soc Ther Radiol Oncol 2003;21(3):238 244˜
242 -
 
Fig. 3.Isodose distributionsuperimposed onasimulation image of (A) coronalplane and (B) sagittal plane that intersects theOSpoint.
A B
Table 2. Dose Difference between the QA Software and Plato for 9
Intracavitary Brachytherapy Plans. NegativeValue Means That theQA
Software PredictionsAreSmallerthan Those of TPS
=======================================================
Differences (%)
----------------------------------------
PatientA point A point B pointB point
number(positive)(n gative)(positive)(n gative)
----------------------------------------------------------
1 1.80－ 0.79－ 4.54－ 2.21－
2 1.96－ 3.36－ 1.96－ 2.89－
3 4.03－ 4.68－ 5.63－ 5.66－
4 2.83－ 2.35－ 2.52－ 1.85－
5 1.29－ 2.86－ 1.21－ 2.09－
6 6.99－ 5.51－ 1.74－ 1.92－
7 0.66－ 4.27－ 3.63－ 4.17－
8 4.41－ 4.99－ 3.98－ 8.48－
9 3.17－ 3.04－ 2.95－ 3.28－
----------------------------------------------------------
Average 3.02－ 3.54－ 3.13－ 3.62－
----------------------------------------------------------
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but any specially individualizedplanneedtobeverified.Also
this software is helpful when commissioning a new HDR
system or a new version of HDR planning software. The
function that can display isodose distributions
superimposed on the simulation images potentially serves
to increase the quality of the individual plan. When MR or
CT images are used, however, it is necessary to recognize
the perceived error that resulted from the positional
difference of the patients when images were taken.
Additionally, the developed QA software not only double
check the source strength of the day by itself, but it
helps the physicist intercept common human errors, such
as mistaken data entries in the optimization routine or
incorrectly specified length.The d ve oped software,
however, has limited accuracy since uses a semi-empirical
formula without considering any inhomogeneity, such as
bony structures, air cavities, and metallic part of the
applicators.
In summary, we have developed a RTP system
comparable QA software for HDR treatment planning,
that assists physci ts in the pretreatment review of
various treatment parameers, and provides an additional
dose verification. The software canbeeasily implemented
into various treatment planning systems and can be
applied to a various kinds of brachytherapy procedures.
The accuracy of the software allows to use the QA
software as a backup method as well.
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고선량률 근접치료계획의 정도보증 프로그램
성균관대학교 의과대학 삼성서울병원 방사선종양학과 연세대학교 의과대학 연세암센터 방사선종양학교실*, †
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목 적:개별화되어 가는고선량률 근접치료계획의 추세에따라 고성량률근접치료계획의 절대적선량과 상대적인,
선량분포를 독립적으로 계산하여 환자의 해부영상위에 겹쳐 표 시 할 수 있 는 품 질 보 증 용 컴 퓨 터 프 로 그 램 을 개 발
한다.
대상 및 방법: 컴퓨터 프로그램은 먼저 환자의 치료계획에서 계산된 선원의 위치 각 위치에서의 조사시간, , ,
에서의선량 치료계획이 실 시 된 날 짜 등 의 자 료 입 력 을 필 요 로 한 다 권고 수식과선원의 비reference point , .ICWG
등방성 표를 이용하여 10×10×12 (cm3 의 공 간 에 서 선 량 분 포 가 계 산 된 후 에서의 선량이 자동적으) reference point
로 치료계획의 결과와 비교된다 모의치료의 영상이나 자기공명 영상을 입 력 하 고 사용자. (Magnetic Resonance)
가 선택한 점을 수직으로 교차하는 개의 평면에서 등선량곡선을 겹쳐서 보여준다 사의3 . Gamma Med Gam-
madot (MDS 에서 표준 치료계획을 실행하여 정확성을 확인하였으며Nordion, Germany) , Plato (Nucletron Cor-
에서 실행된 명의 환자치료계획과 비교하였다poration, The Netherlands) 9 .
결 과: 개의 표준치료계획에서 절대선량은 내에서 일치하였으며등 선량분포도 좋 은 일 치 를 보 였 다 명의3 2.8% . 9
환자에 대하여 시행된 치료계획과의 비교에서는 평균 의 오차를 보였다3.4% .
결 론: 개발된 컴퓨터 프로그램은 정확하고 신속하게 고선량률 치료환자의 치료계획의 정확성을 확인할 수 있게
해주며 등선량 곡선을 환자의 해부적 영상에 결합할 수 있는 기능은 치료계획의 질을 높이는데 기여할 수 있을,
것으로 기대된다.
핵심용어: 정도보증 고선량률 근접치료,
국문초록
